OBJECTIVES: The objectives of this study were to report the surgical techniques and clinical outcome of thoracoscopic lobectomy with partial removal of the superior vena cava for @entity2 . METHODS: Between January 2010 and November 2013, 1132 @entity1 with @entity2 underwent radical surgery by thoracoscopy; 5 (0.4%) underwent thoracoscopic lobectomy with partial removal of the superior vena cava. Perioperative variables and postoperative outcomes of these cases were analysed to evaluate the technical feasibility and safety of this operation. RESULTS: For all cases, a right upper lobectomy was performed. The average time of surgery was 260 min (range, 170-380, 260    90 min).The intraoperative @entity190 averaged 160 ml (range, 50-300, 160    90 ml). The median postoperative hospital stay was 11 days (interquartile range, 7-15 days). Postoperatively, tracheal extubation was achieved in the recovery room without further need for mechanical ventilation. In 1 case, the @entity1 experienced postoperative superior vena cava @entity715 ; he recovered after administration of anticoagulation drugs. None of the @entity1 developed active blood leakage postoperatively. Perioperative mortality was not observed. CONCLUSION: Thoracoscopic lobectomy with partial removal of the superior vena cava can be considered a feasible and safe operation for selected @entity1 with @entity2 .

Initial experience of thoracoscopic lobectomy with partial removal of the superior vena cava for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis'] @entity2 :: ('MESH:D008175', 'Disease') :: ['lung cancer', 'lung carcinomas'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss']
@entity2 :: (MESH:D008175,Disease) :: ['lung cancers']
